GENFLEET-B (02595): A total of 872,000 H shares repurchased as of September 18
GenFleet Therapeutics-B (02595) announced that as of September 18, 2026, the Company conducted a series of H share repurchases on The Stock Exchange of Hong Kong Limited, repurchasing a total of 872,000 H shares, representing approximately 0.227% of the Company's total issued share capital as of the date of this announcement. The Company may assess market conditions and continue to implement its 2026 H share repurchase plan.
GENFLEET-B (02595) announced that as of September 18, 2026, the company conducted a series of H share repurchases on The Stock Exchange of Hong Kong Limited, repurchasing a total of 872,000 H shares, representing approximately 0.227% of the company's total issued share capital as of the date of this announcement. The company may assess market conditions and continue to implement its 2026 H share repurchase plan.
Related Articles
US IPO Analysis | Jingrui Wangpu: Raising Approximately $37.5 Million Can the "Store + Wholesale" Dual Engine Support Its Valuation?
HK Stock Market Move | METIS TECHBIO-P (07666) rose nearly 7% in morning trading. The core competitiveness of Biological AI lies in real experimental data.
The Pacific Securities: The lepidolite industry continues to upgrade; pay attention to long-term opportunities in the industry chain.
US IPO Analysis | Jingrui Wangpu: Raising Approximately $37.5 Million Can the "Store + Wholesale" Dual Engine Support Its Valuation?
HK Stock Market Move | METIS TECHBIO-P (07666) rose nearly 7% in morning trading. The core competitiveness of Biological AI lies in real experimental data.
The Pacific Securities: The lepidolite industry continues to upgrade; pay attention to long-term opportunities in the industry chain.
RECOMMEND
